BrainQ, an Israeli stroke therapy technology company, closed a funding round worth $40 million. Hanaco Ventures led the raise in addition to Dexcel Pharma, Peregrine Ventures and the company’s existing investors.
These funds bring BrainQ’s total amount raised to over $50 million, according to the announcement.
WHAT IT DOES
BrainQ’s technology uses AI to deliver electromagnetic field therapy to...
